ABVC BioPharma Inc (ABVC)
1.08
-0.07
(-6.09%)
USD |
NASDAQ |
May 03, 16:00
1.13
+0.05
(+4.63%)
After-Hours: 20:00
ABVC BioPharma Price to Book Value: 1.360 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 03, 2024 | 1.360 |
May 02, 2024 | 1.448 |
May 01, 2024 | 1.423 |
April 30, 2024 | 1.574 |
April 29, 2024 | 1.763 |
April 26, 2024 | 1.788 |
April 25, 2024 | 2.002 |
April 24, 2024 | 1.863 |
April 23, 2024 | 1.700 |
April 22, 2024 | 1.309 |
April 19, 2024 | 1.246 |
April 18, 2024 | 1.322 |
April 17, 2024 | 1.284 |
April 16, 2024 | 1.410 |
April 15, 2024 | 1.372 |
April 12, 2024 | 1.372 |
April 11, 2024 | 1.448 |
April 10, 2024 | 1.435 |
April 09, 2024 | 1.486 |
April 08, 2024 | 1.574 |
April 05, 2024 | 1.599 |
April 04, 2024 | 1.612 |
April 03, 2024 | 1.624 |
April 02, 2024 | 1.624 |
April 01, 2024 | 1.725 |
Date | Value |
---|---|
March 28, 2024 | 1.649 |
March 27, 2024 | 1.511 |
March 26, 2024 | 1.612 |
March 25, 2024 | 1.322 |
March 22, 2024 | 1.347 |
March 21, 2024 | 1.334 |
March 20, 2024 | 1.348 |
March 19, 2024 | 1.410 |
March 18, 2024 | 1.460 |
March 15, 2024 | 1.473 |
March 14, 2024 | 1.511 |
March 13, 2024 | 1.548 |
March 12, 2024 | 1.586 |
March 11, 2024 | 1.536 |
March 08, 2024 | 1.574 |
March 07, 2024 | 1.275 |
March 06, 2024 | 1.265 |
March 05, 2024 | 1.234 |
March 04, 2024 | 1.265 |
March 01, 2024 | 1.203 |
February 29, 2024 | 1.234 |
February 28, 2024 | 1.239 |
February 27, 2024 | 1.254 |
February 26, 2024 | 1.265 |
February 23, 2024 | 1.224 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4293
Minimum
Oct 06 2023
263.24
Maximum
Sep 30 2019
28.84
Average
8.809
Median
Price to Book Value Benchmarks
NeuBase Therapeutics Inc | 0.1653 |
Sutro Biopharma Inc | 1.969 |
Reviva Pharmaceuticals Holdings Inc | 15.62 |
Flora Growth Corp | 2.820 |
Journey Medical Corp | 3.614 |
Price to Book Value Related Metrics
PS Ratio | 32.92 |
Price | 1.08 |
Earnings Yield | -230.8% |
Market Cap | 11.41M |